A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

Founded in 2011, HyperStrong has established itself as a trusted partner in the global transition to renewable energy. The company provides a wide range of energy storage solutions including ...

Chinese biotech Ascentage Pharma has taken the first US biotech initial public offering (IPO) of 2025 over the finish line, ...

Loeb & Loeb, which launched a Beijing office in 2008, has been playing the long game and is now outgunning the likes of ...

Venture Global’s stock fell about 4% below its initial public offering price in its market debut on Friday, after the liquefied natural gas ...

Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise ...

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

EcoCeres Inc., a producer of sustainable fuel backed by Bain Capital, is exploring an initial public offering that could ...

SMITHFIELD FOODS INC (SFD) plans to raise $870 million in an initial public offering on Tuesday, January 28th, IPO Scoop ...

In addition, MPACT is exposed to foreign currency risk as about half of its assets under management are outside of Singapore. This is managed by using foreign currency-denominated borrowings as a ...

The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.